ATE198987T1 - Behandlung von tropikalischer spastischer paresis mit peptide t - Google Patents

Behandlung von tropikalischer spastischer paresis mit peptide t

Info

Publication number
ATE198987T1
ATE198987T1 AT93303919T AT93303919T ATE198987T1 AT E198987 T1 ATE198987 T1 AT E198987T1 AT 93303919 T AT93303919 T AT 93303919T AT 93303919 T AT93303919 T AT 93303919T AT E198987 T1 ATE198987 T1 AT E198987T1
Authority
AT
Austria
Prior art keywords
thr
amino
peptides
ser
residue
Prior art date
Application number
AT93303919T
Other languages
English (en)
Inventor
Candace B Bert
Michael R Ruff
Original Assignee
Advanced Peptides & Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Peptides & Biotech filed Critical Advanced Peptides & Biotech
Application granted granted Critical
Publication of ATE198987T1 publication Critical patent/ATE198987T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT93303919T 1992-06-15 1993-05-20 Behandlung von tropikalischer spastischer paresis mit peptide t ATE198987T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/898,691 US6242564B1 (en) 1986-06-03 1992-06-15 Treatment of tropical spastic paresis with peptide T

Publications (1)

Publication Number Publication Date
ATE198987T1 true ATE198987T1 (de) 2001-02-15

Family

ID=25409893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93303919T ATE198987T1 (de) 1992-06-15 1993-05-20 Behandlung von tropikalischer spastischer paresis mit peptide t

Country Status (8)

Country Link
US (1) US6242564B1 (de)
EP (1) EP0579363B1 (de)
JP (1) JPH06247874A (de)
AT (1) ATE198987T1 (de)
AU (1) AU671989B2 (de)
DE (1) DE69329899T2 (de)
DK (1) DK0579363T3 (de)
IL (1) IL105822A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567682A (en) * 1988-12-16 1996-10-22 Advanced Peptides And Biotechnology Sciences Method of treating Alzheimer's disease
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
DE69433817T2 (de) * 1993-09-24 2005-07-14 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis
AU697847B2 (en) * 1993-09-24 1998-10-15 Advanced Immunit, Inc. Method for the treatment or prevention of eczema/dermatitis
AUPM365794A0 (en) * 1994-02-02 1994-02-24 Minister for Agriculture & Rural Affairs for the State of NSW, The Biocontrol of take-all using phialophora sp. (lobed hyphopodia)
US5990172A (en) * 1996-02-28 1999-11-23 Innapharma, Inc. Peptidomimetics for the treatment of HIV infection
IL149443A0 (en) * 1999-11-09 2002-11-10 Advanced Immuni T Inc Compositions for treating viral diseases
US7700115B2 (en) 2005-06-23 2010-04-20 Rapid Pharmaceuticals Ag Therapeutic peptides and vaccines
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
US10501494B2 (en) 2013-04-26 2019-12-10 Creative Bio-Peptides Uses of peptides to treat brain injury and disease
US10624944B2 (en) * 2017-06-19 2020-04-21 Creative Bio-Peptides Inc. Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
WO1987007614A1 (en) * 1986-06-03 1987-12-17 Pert Candace B Small peptides which inhibit binding to t-4 receptors
EP0249394B1 (de) * 1986-06-03 1993-10-27 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken
EP0415999B1 (de) * 1988-05-27 1998-07-22 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
US5689398A (en) * 1996-01-03 1997-11-18 Allen-Bradley Company, Inc. Redundant control relay circuits

Also Published As

Publication number Publication date
IL105822A0 (en) 1993-09-22
JPH06247874A (ja) 1994-09-06
AU671989B2 (en) 1996-09-19
DE69329899T2 (de) 2001-05-23
US6242564B1 (en) 2001-06-05
DE69329899D1 (de) 2001-03-08
EP0579363B1 (de) 2001-01-31
IL105822A (en) 1999-11-30
DK0579363T3 (da) 2001-02-19
EP0579363A1 (de) 1994-01-19
AU3871993A (en) 1993-12-16

Similar Documents

Publication Publication Date Title
DE69032600D1 (de) Rekombinanter abkömmling des menschlichen faktors iii
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
ATE198987T1 (de) Behandlung von tropikalischer spastischer paresis mit peptide t
ES2075040T3 (es) 2',3'-dideoxi-2',2'-difluoronucleosidos.
DE69311427D1 (de) Synthetische Polypeptide als Inhibitoren von HIV-1
DE69731097D1 (de) Conotoxin peptid pviia
DK0466174T3 (da) Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
DK0573538T3 (da) Peptider til behandling
ATE96450T1 (de) Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE124955T1 (de) Substrat-peptide.
CO4930283A1 (es) Analogos peptidos lh-rh, su empleo y composiciones farmaceu- ticas que los contienen
DK0426314T3 (da) HIV-relaterede peptider
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
ATE92078T1 (de) Pharmakologisch aktive peptide.
CA1090784A (en) Synthesis for peptides
WO1994004565A3 (en) Ipnv vaccine
WO1997025343A3 (en) Antithrombotic agents and methods of use
ATE46173T1 (de) Pharmakologisch aktive peptide.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties